Celldex Therapeutics
CLDX
#4691
Rank
A$2.97 B
Marketcap
A$44.74
Share price
6.44%
Change (1 day)
8.27%
Change (1 year)

Celldex Therapeutics (CLDX) - Total debt

Total debt on the balance sheet as of September 2025 : A$3.96 Million

According to Celldex Therapeutics's latest financial reports the company's total debt is A$3.96 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Celldex Therapeutics - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$6.13 M64.3%
2023-12-31A$3.73 M-37.04%
2022-12-31A$5.92 M41.24%
2021-12-31A$4.19 M-7.31%
2020-12-31A$4.52 M-13.33%
2019-12-31A$5.22 M
2018-12-31N/A-100%
2017-12-31A$8.41 M
2015-12-31A$6.06 M91.48%
2014-12-31A$3.16 M
2013-12-31N/A-100%
2012-12-31A$10.91 M-26.13%
2011-12-31A$14.76 M38.68%
2010-12-31A$10.64 M-30.87%
2009-12-31A$15.4 M4886.09%
2008-12-31A$0.3 M-94.77%
2007-12-31A$5.91 M0.37%
2006-12-31A$5.88 M106.44%
2005-12-31A$2.85 M1083.73%
2004-12-31A$0.24 M
2000-12-31A$0.49 M-42.69%
1999-12-31A$0.85 M-67.22%
1998-12-31A$2.61 M6.4%
1997-12-31A$2.45 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Seagen
SGEN
A$0.17 B 4,229.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$69.17 M 1,646.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.00 B 25,199.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$82.50 B 2,082,578.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$91.96 B 2,321,456.66%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$36.06 B 910,315.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA